Vanguard Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$238M Buy
2,089,371
+33,639
+2% +$3.82M ﹤0.01% 1430
2025
Q1
$216M Sell
2,055,732
-29,895
-1% -$3.14M ﹤0.01% 1448
2024
Q4
$223M Buy
2,085,627
+115,005
+6% +$12.3M ﹤0.01% 1493
2024
Q3
$197M Buy
1,970,622
+43,748
+2% +$4.38M ﹤0.01% 1550
2024
Q2
$162M Buy
1,926,874
+42,762
+2% +$3.6M ﹤0.01% 1606
2024
Q1
$138M Buy
1,884,112
+7,598
+0.4% +$555K ﹤0.01% 1701
2023
Q4
$134M Buy
1,876,514
+24,653
+1% +$1.76M ﹤0.01% 1707
2023
Q3
$111M Sell
1,851,861
-1,492
-0.1% -$89.4K ﹤0.01% 1750
2023
Q2
$134M Sell
1,853,353
-5,261
-0.3% -$379K ﹤0.01% 1689
2023
Q1
$137M Buy
1,858,614
+15,499
+0.8% +$1.14M ﹤0.01% 1657
2022
Q4
$123M Sell
1,843,115
-1,031,728
-36% -$68.9M ﹤0.01% 1695
2022
Q3
$154M Buy
2,874,843
+31,163
+1% +$1.67M ﹤0.01% 1540
2022
Q2
$158M Buy
2,843,680
+74,276
+3% +$4.13M ﹤0.01% 1564
2022
Q1
$194M Buy
2,769,404
+17,478
+0.6% +$1.23M ﹤0.01% 1573
2021
Q4
$265M Sell
2,751,926
-8,906
-0.3% -$858K 0.01% 1432
2021
Q3
$240M Buy
2,760,832
+317,612
+13% +$27.6M 0.01% 1493
2021
Q2
$200M Buy
2,443,220
+9,478
+0.4% +$776K 0.01% 1632
2021
Q1
$231M Buy
2,433,742
+95,085
+4% +$9.04M 0.01% 1509
2020
Q4
$145M Buy
2,338,657
+47,500
+2% +$2.95M ﹤0.01% 1646
2020
Q3
$136M Sell
2,291,157
-91,868
-4% -$5.46M ﹤0.01% 1513
2020
Q2
$166M Sell
2,383,025
-172,077
-7% -$12M 0.01% 1395
2020
Q1
$116M Buy
2,555,102
+38,371
+2% +$1.74M ﹤0.01% 1446
2019
Q4
$164M Sell
2,516,731
-115,494
-4% -$7.51M 0.01% 1494
2019
Q3
$163M Sell
2,632,225
-110,542
-4% -$6.86M 0.01% 1456
2019
Q2
$195M Sell
2,742,767
-354,543
-11% -$25.2M 0.01% 1375
2019
Q1
$243M Buy
3,097,310
+3,760
+0.1% +$295K 0.01% 1224
2018
Q4
$262M Sell
3,093,550
-256,940
-8% -$21.8M 0.01% 1072
2018
Q3
$574M Buy
3,350,490
+107,063
+3% +$18.3M 0.02% 721
2018
Q2
$419M Buy
3,243,427
+130,815
+4% +$16.9M 0.02% 868
2018
Q1
$321M Buy
3,112,612
+150,566
+5% +$15.5M 0.01% 989
2017
Q4
$253M Buy
2,962,046
+120,603
+4% +$10.3M 0.01% 1139
2017
Q3
$241M Buy
2,841,443
+49,309
+2% +$4.19M 0.01% 1129
2017
Q2
$211M Buy
2,792,134
+86,882
+3% +$6.58M 0.01% 1196
2017
Q1
$179M Buy
2,705,252
+118,932
+5% +$7.85M 0.01% 1295
2016
Q4
$164M Buy
2,586,320
+86,698
+3% +$5.5M 0.01% 1303
2016
Q3
$159M Buy
2,499,622
+69,772
+3% +$4.44M 0.01% 1264
2016
Q2
$181M Buy
2,429,850
+179,227
+8% +$13.3M 0.01% 1111
2016
Q1
$150M Buy
2,250,623
+89,053
+4% +$5.95M 0.01% 1189
2015
Q4
$146M Buy
2,161,570
+24,744
+1% +$1.67M 0.01% 1206
2015
Q3
$114M Buy
2,136,826
+34,070
+2% +$1.82M 0.01% 1342
2015
Q2
$132M Buy
2,102,756
+472,712
+29% +$29.8M 0.01% 1346
2015
Q1
$78.4M Buy
1,630,044
+31,446
+2% +$1.51M 0.01% 1670
2014
Q4
$53.1M Buy
1,598,598
+123,838
+8% +$4.11M ﹤0.01% 1801
2014
Q3
$43.2M Sell
1,474,760
-198,423
-12% -$5.82M ﹤0.01% 1880
2014
Q2
$65M Buy
1,673,183
+95,448
+6% +$3.71M 0.01% 1695
2014
Q1
$66.2M Buy
1,577,735
+487,668
+45% +$20.5M 0.01% 1638
2013
Q4
$35.8M Buy
1,090,067
+204,235
+23% +$6.7M ﹤0.01% 1943
2013
Q3
$23.9M Buy
885,832
+15,267
+2% +$412K ﹤0.01% 2047
2013
Q2
$20.3M Buy
+870,565
New +$20.3M ﹤0.01% 2063